Introduction
Schizophrenia and bipolar disorder (BD) are 2 disabling mental illnesses, each with a prevalence of approximately 25-30 million people worldwide. 1 While the causes are unknown, brain im aging studies have implicated white matter dysfunction in indi viduals with these disorders. 2, 3 Specifically, disruption of frontal white matter tracts has been identified by diffusion tensor im aging in both schizophrenia 4 and BD populations, 5 while meta analyses have revealed reduced crosssectional area of the corpus callosum. 6, 7 In addition, frontal white matter hyperintensities are more common in BD than in control populations. 7 The molecular and cellular correlates of these imaging findings remain to be elucidated, although glial cells have been implicated in both disorders. While we previously re ported lower glial density in temporal white matter in a schizophrenia sample, 8 it is unknown if this deficit is specific to any individual glial population (i.e., oligodendrocytes, as trocytes, microglia). Hof and colleagues 9 have reported de creased oligodendrocyte density in frontal white matter in a schizophrenia sample, while molecular alterations related to oligodendrocytes and the myelin sheath, including reduced expression of 2′,3′cyclicnucleotide 3′phosphodiesterase (CNPase), have been noted in this disorder. 10, 11 However, others have found no significant change in oligodendrocyte density in white matter in schizophrenia or BD samples [12] [13] [14] [15] and no change in the oligodendrocyteassociated proteins myelin basic protein (MBP) or CNPase in schizophrenia sam ples. 16, 17 Astrocyte and microglial populations have rarely been studied in white matter in individuals with these disor ders, although decreased astrocyte density in cingulate white matter in schizophrenia, but not BD samples, 15 and increased density of activated microglia in frontal white matter in schizophrenia samples 18 have been reported.
Considering that white matter plays an essential role in com munication between brain regions, abnormalities of white mat ter glia could lead to alterations in structural or functional sup port of axons, ultimately contributing to disturbed neural connectivity in individuals with schizophrenia and BD. The purpose of the present study was to assess the 3 major glial popu lations in wellcharacterized postmortem tissues from schizophrenia, BD and nonpsychiatric control samples. The density, area fraction and spatial distribution of glial fibrillary acidic protein (GFAP)-expressing astrocytes and ionized cal cium binding adaptor molecule1 (IBA1)expressing microglia as well as the density, nuclear size and spatial distribution of Nisslstained oligodendrocytes were quantified in white matter underlying the dorsolateral prefrontal cortex (DLPFC). In addi tion, given that we did not use a cellspecific marker for oligo dendrocytes, we further examined alterations in this glial popu lation by quantifying levels of the oligodendrocyteassociated proteins MBP and CNPase in the same sample using enzyme linked immunosorbent assay (ELISA) and immunoblotting.
Methods

Population
We obtained postmortem brain tissue from the Stanley Med ic al Research Institute's brain collection (array collection). The population comprised samples from 60 people: 20 who had schizophrenia, 20 who had BD and 20 who were nonpsychiat ric controls. Brain tissue was collected as previously de scribed. 19 Diagnoses were made according to DSMIV criteria. Routine neuropathological examinations found no evidence of neurodegenerative changes or pathological lesions. Demo graphic and clinical details are summarized in Table 1 .
Immunohistochemistry
Tissue blocks were dissected from the middle frontal gyrus, ros tral to the genu of the corpus callosum, from either the left or right hemisphere. Tissue was embedded in paraffin, serially sec tioned in the coronal plane at 6 µm and mounted onto glass slides. A series of 15 paraffinembedded sections containing the DLPFC (Brodmann Area [BA] 9) and underlying white matter was made available to us. For each antibody, 3 sections were se lected per individual, with an interval of 30 µm between sec tions. To optimize antigen retrieval, sections were heated at 95°C in 0.01 M citrate buffer (pH 6) for 10 minutes (IBA1) or 15 minutes (GFAP). We performed GFAP immunostaining using an ABC kit (Vector Laboratories), with overnight incuba tion at 4°C in a mouse monoclonal antibody (Sternberger Mono clonal Inc; 1:8000) and visualization with diaminobenzadine (DAB; Vector Laboratories). For IBA1 immunostaining, sections were incubated overnight at 4°C in a rabbit polyclonal antibody Astrocytes and oligodendrocytes were counted on composite images from GFAPstained sections. Astrocytes were identified as cells with GFAPpositive cell bodies and processes that dis played classic astrocytic morphology (Fig. 1A) . Nisslstained oli godendrocytes were differentiated from other cell types by the presence of a small round or oval nucleus, more heterogeneous chromatin within the nucleus and a narrow rim of cytoplasm (Fig. 1A) . Only oligodendrocytes with nuclei 3-7 µm in diameter were counted. 20 Oligodendrocyte nuclear size was assessed in 1 counting frame per individual (approximately 460 cells/ individual) using a 2step editing process. 8, 21 The Abercrombie correction factor 22 was applied to oligodendrocyte density data to correct for potential bias due to section thickness and cell size. Microglial cells were counted on composite images from IBA1 stained sections. Perivascular microglial cells located within blood vessels (Fig. 1B) were excluded from the microglial counts. Considering IBA1 labels both activated and resting micro glia, a qualitative neuropathological assessment of micro glia morphology was also conducted. Microglia were classified as activated if cell bodies were enlarged and poorly defined, with thickening of processes near the soma and overall fewer and shorter processes (Fig. 1C) . Cases containing areas of unam biguous microglial activation were noted.
A total of 302 040 cells were counted, comprising 236 731 oligodendrocytes, 33 593 astrocytes and 31 716 microglia. Co efficients of error 23 were 0.016 for oligodendrocytes and 0.043 for astrocytes and microglia. The reliability of astrocyte, oli godendrocyte and microglial cell counts was assessed by requantifying 5 cases chosen at random. Intrarater correlation coefficients were 0.981, 0.985 and 0.990, respectively.
Area fraction
The area occupied by GFAPpositive astrocytes and IBA1 positive microglia was examined in each counting frame.
Briefly, colour composite images were converted into greyscale and immunoreactive structures segmented by first defining an average background level in an area without staining, then sub tracting a fixed level of 30 grey values from the background in tensity level. Grey levels ranged from 0 (darkest) to 255 (light est). Thresholded areas were outlined and summed, yielding the percentage area of GFAP (Fig. 1D) or IBA1 (Fig. 1E) staining.
Spatial pattern analysis
To estimate the spatial distribution of oligodendrocytes, astro cytes and microglia, we used a 2dimensional Voronoi tessella tion approach. 24, 25 Maps of the distribution of oligodendrocytes, astrocytes and microglia were constructed separately with Voron software (courtesy of Dr. Charles Duyckaerts) used to compute Voronoi tessellation. All counting frames were ana lyzed, and mean coefficients of clustering (CC) were obtained. The CC yields a measure of the distribution of cells; a CC tend ing toward 1 represents a random distribution, whereas a higher ratio represents a more clustered distribution.
Quantification of oligodendrocyte-associated proteins
Frozen white matter from the opposite hemisphere of the same individuals was homogenized in 10 volumes of icecold tris buffered saline and stored at -80°C until required. Total protein concentrations were determined using the DC Pro tein Assay (BioRad). We quantified MBP using ELISA, as previously de scribed 16, 26 with minor modifications. Briefly, duplicate sam ples were serially diluted over a 128fold range with a start ing concentration of 15 µg/mL. Plates were incubated overnight at 4°C with a mouse monoclonal antibody (Stern berger Monoclonal Inc.; 1:1000). Plates were subsequently incubated with peroxidaseconjugated goat antimouse (Jack son Immunoresearch; 1:1000), then with 2,2′azinodi3 ethylbenzthiazoline (KPL Inc.). The optical density of each well was determined at 405 nm using a microplate reader (Molecular Devices). The optical density was determined at a protein concentration of 5 µg, within the linear range for each sample, and compared between samples. Each sample was run twice on different days, resulting in a betweenrun cor rel ation of r = 0.80, with mean values used for analysis.
We quantified CNPase by immunoblotting. Briefly, 3 µg protein/lane was run on 12% polyacrylamide gels, then transblotted to polyvinylidene fluoride membranes. Pilot studies indicated that this concentration fell within the lin ear range of detection of our assay. Blots were stained for total protein using MemCode reversible protein stain (Thermo Scientific) and imaged using a LAS 3000 Lumines cence Image Analyzer (FujiFilm). Blots were then incubated with a mouse monoclonal antibody CNPase (Sternberger Monoclonal Inc.; 1:3000). Following incubation with peroxidaseconjugated goat antimouse (Jackson Immuno research; 1:1000), chemiluminescence substrate (ECL, GE Healthcare) was applied and blots reimaged. Four pooled standard samples were included on each gel to act as a betweengel reference. Blot images were quantified using Science Laboratory Image Gauge (FujiFilm). The intensity of each band of interest was normalized both to the average band intensity of the adjacent pooled standards (to account for blottoblot variability) and to the total protein stain for that lane (to account for variations in sample loading and transfer), as previously described. 27 Samples were run twice on different days, resulting in a betweenrun correlation of r = 0.84, with mean values used for analysis.
Statistical analysis
The main objective of this study was to compare oligoden drocyte, astrocyte and microglial measures between each of the patient groups and the control group. Normality was ver ified using Shapiro-Wilks tests and, when necessary, data were transformed to conform to a normal distribution. Betweengroup comparisons were made by univariate analy sis of variance (ANOVA) using diagnoses as contrasts. Type I error was set at 0.05. We performed Pearson correlations to examine the association between age, postmortem interval (PMI) and pH and cellular or protein measures. When data were not normally distributed we used Spearman rank cor rel ations. We examined the influence of the variables sex and hemisphere separately using 2way ANOVA. If a significant association was found between any of these continuous or categorical variables and cellular or protein measures, we in cluded them as covariates or fixed factors in an additional analysis of covariance (ANCOVA) model.
Secondary analyses were performed to assess the potential impact of suicide, prescribed medication and substance use on cellular or protein measures. The effect of suicide was as sessed by ANOVA, with post hoc least significant difference (LSD) tests. In the schizophrenia group, the association be tween estimated lifetime antipsychotic dose (fluphenazine equivalents) and cellular and protein measures was deter mined using Pearson or Spearman rank correlations. We used ANOVA or ANCOVA analyses to examine the effect of prescribed mood stabilizers and antidepressants within the BD group and the effect of illicit drug or alcohol use within both patient groups. We divided the samples into those with none/social drug or alcohol use and those with moderate/ heavy drug or alcohol use according to Brain Bank criteria. Analyses were carried out in SPSS software version 15. Increasing evidence suggests that men and women exhibit distinct pathophysiology in schizophrenia and BD. 28, 29 We therefore assessed the influence of sex on our cellular and protein measures using 2way ANOVAs. We observed a main effect of sex on oligodendrocyte nuclear area (F 1,54 = 5.20, p = 0.027) and oligodendrocyte diameter (F 1,54 = 5.28, p = 0.025), with men having larger cell sizes than women. We also noted an effect of sex on MBP levels (F 1,54 = 6.60, p = 0.013), with protein expression being higher in men. There was no main effect of hemisphere on any cytoarchitectural measure, although we observed an effect of hemisphere on CNPase levels (F 1,54 = 4.85, p = 0.032), with protein expression higher in the left hemisphere in all groups.
Results
Influence of demographic and clinical characteristics
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Cell density
Cell density results are listed in Table 2 . We observed a sig nificant effect of diagnosis on oligodendrocyte density (F 2,57 = 4.78, p = 0.012), reflecting increased oligodendrocyte density in the BD group compared with the control group (17%, p = 0.011). There was no difference between the schizophrenia and control groups. Given the controversy surrounding the application of the Abercrombie correction for cell size, 30 we repeated the analysis without the use of the Abercrombie cor rection. In this case the nature of the results was not altered (F 2,57 = 5.10, p = 0.009). The oligodendrocyte nuclear area and diameter did not differ among the groups. While the density of GFAPimmunoreactive (GFAPIR) astrocytes did not differ significantly among the groups, we observed a trend toward decreased astrocyte density in the schizophrenia group (p = 0.06, 10%). We excluded samples from 4 individuals from the analysis of IBAIR micro glia owing to lack of staining. Fol lowing logarithmic transformation, microglial density data attained a normal distribution. The density of IBA1stained microglia did not differ among the groups; however, a quali tative assessment of microglial morphology found numerous activated microglial cells in 3 schizophrenia samples, but not in control or BD samples.
Area fraction
The ANOVA model indicated that GFAP area fraction differed among the groups (F 2,57 = 3.16, p = 0.05), reflecting decreased GFAP area fraction in both the schizophrenia (24%, p = 0.044) and BD (27%, p = 0.027) groups compared with the control group. However, following addition of brain pH as a covariate in the model, this finding did not attain statistical significance. The IBA1 area fraction did not differ among the groups.
Spatial distribution
Oligodendrocyte CC and microglial CC data were trans formed using logarithmic and reciprocal transformations, re spectively. We observed a significant effect of group on astro cyte CC (F 2,57 = 3.41, p = 0.040), reflecting significantly higher astrocyte CC in the schizophrenia (p = 0.031) and BD (p = 0.025) groups than in the control group, which is indicative of a more clustered distribution of GFAPpositive astrocytes in the psychiatric groups. Oligodendrocyte and microglial CC did not differ among the groups.
Oligodendrocyte-associated proteins
We observed a significant effect of diagnosis on CNPase (F 2,57 = 3.46, p = 0.038). Addition of hemisphere in an ANCOVA model did not alter the nature of the results (F 2,54 = 3.39, p = 0.041). Protein levels were increased by 21% in the BD group and decreased by 17% in the schizophrenia group (Fig. 2) ; however, this did not reach statistical signifi cance for either group individually. There was no difference in MBP among the groups.
Influence of suicide, medication and substance use
Suicidal behaviours may share common pathologies not as sociated with any specific psychiatric diagnosis. 31, 32 Measures were compared in all psychiatric patients who died by sui cide (n = 10), all psychiatric patients who died by other means (n = 30) and controls (n = 20). Astrocyte densities dif fered significantly among the groups (F 2,57 = 4.12, p = 0.021), with post hoc LSD tests indicating that the psychiatric non suicide group had significantly lower astrocyte densities than the control group (p = 0.025) and the suicide group (p = 0.022; 3A ). Similar differences were also seen for GFAP area fraction (F 2,57 = 13.34, p < 0.001), with post hoc LSD tests indi cating that the psychiatric nonsuicide group had significantly lower GFAP area fraction than the control group (p < 0.001) and the suicide group (p < 0.001; Fig. 3B ). Following addition of brain pH as a covariate in the model, a significant group effect remained (F 2,56 = 9.51, p < 0.001), with post hoc tests in dicating that the psychiatric nonsuicide group had signifi cantly lower GFAP area fraction than the control group (p = 0.008) and the suicide group (p < 0.001). In addition, the spa tial distribution of GFAPIR cells differed among the groups (F 2,57 = 3.44, p = 0.039), with the psychiatric nonsuicide group having significantly higher astrocyte CC than the control group (p = 0.013), indicating increased astrocyte clustering. Oligodendrocyte CC also differed among the groups (F 2,57 = 4.17, p = 0.020), with the suicide group showing higher oligo dendrocyte CCs than the control group (p = 0.007) and the psychiatric nonsuicide group (p = 0.018).
In the schizophrenia group lifetime estimated anti psychotic dose correlated with oligodendrocyte CC (r = -0.58, p = 0.007), but no other measure. The patients who had BD and who had been prescribed mood stabilizers (n = 14) showed a trend toward increased oligodendrocyte density relative to those who had not been prescribed mood stabiliz ers (n = 6; F 1,18 = 4.27, p = 0.05). The patients who had BD and who had been prescribed antidepressants (n = 14) had in creased MBP immunoreactivity relative to those who had not been prescribed antidepressants (n = 6; F 1,18 = 7.44, p = 0.014). However, this finding failed to reach statistical significance following addition of PMI and sex in an ANCOVA model. To assess the potential influence of substance use on our findings, we examined the effect of alcohol use and illicit drug use on cellular and protein measures in the psychiatric groups. Oligodendrocyte densities were higher in the pa tients with BD who had documented moderate/heavy alco hol use (n = 14; F 1,18 = 6.11, p = 0.024) and moderate/heavy drug use (n = 10; F 1,18 = 4.78, p = 0.042) than in those with no or low alcohol (n = 6) or drug (n = 10) use. CNPase levels were increased in patients with schizophrenia who had docu mented moderate/heavy alcohol use (n = 9; F 1,18 = 5.00, p = 0.038) and moderate/heavy drug use (n = 7; F 1,16 = 9.47, p = 0.007) than in those with no or low alcohol (n = 11) or drug (n = 11) use. Addition of hemisphere in an ANCOVA model did not change the nature of the results.
Discussion
While imaging studies have reported white matter abnormal ities in individuals with schizophrenia and BD, the cellular correlates of these changes remain to be elucidated. To ad dress this we undertook a comprehensive assessment of indi vidual glial subpopulations in white matter underlying the DLPFC in postmortem samples of schizophrenia, BD and nonpsychiatric controls.
Our main finding was a significant increase in oligoden drocyte density in the BD group. This outcome is contrary to 3 previous studies that found no significant change in oligo dendrocyte density, also determined using Nissl staining, in the white matter of patients with this disorder. [13] [14] [15] This in consistency may reflect variations in methodology, for exam ple use of 2dimensional versus 3dimenstional counting methods or brain region examined (prefrontal versus cingu late or corpus callosum). In addition, these studies used sepa rate brain collections with different sample characteristics. Of note, we also found a significant effect of diagnosis on CNPase levels; CNPase was increased by 21% in the BD group, and although this finding did not attain statistical sig nificance, we believe it to be consistent with increased oligo dendrocytes in this disorder. CNPase is present in oligoden drocyte cell bodies and is frequently used as a marker for this cell population. 33 One explanation for the observed increase in oligodendrocyte density in BD is abnormal regulation of the oligodendrocyte cell cycle, as previously implicated in schizophrenia. 34 An alternative theory is that increased cell density could reflect a compensatory mechanism to help re place damaged myelin. Increased lipid peroxidation has been noted in the myelin fraction in individuals with BD. 35 Oligo dendrocyte precursor cells (OPCs) present during develop ment typically differentiate into mature oligodendrocytes during myelination; however, a population of OPCs persists in the adult brain. 36 In response to demyelination signals, adult OPCs proliferate and differentiate into mature oligo dendrocytes capable of remyelination. 37 We found no signifi cant change in MBP, an oligodendrocyteassociated protein primarily located in compact myelin, in the BD group, which implies that the increase in oligodendrocytes may not be ac companied by higher white matter myelin concentration. To our knowledge, MBP and CNPase levels have not previously been quantified in white matter in individuals with BD. We failed to find any significant change in oligodendrocyte den sity in white matter in individuals with schizophrenia, con sistent with several previous studies of this disorder. [12] [13] [14] [15] Our data suggest that mood stabilizers, alcohol use and il licit drug use may influence oligodendrocyte density in indi viduals with BD. While our sample sizes are small, increased oligodendrocyte density was only present in the patients with BD who had been prescribed mood stabilizers. The ef fect of mood stabilizers on white matter is not fully under stood. Lithium increases axial diffusivity in white matter in patients with BD 38 and reduces demyelination in an animal model of experimental autoimmune encephalomyelitis. 39 However, an inhibitory effect of lithium on proliferating OPCs has also been noted, 40 along with decreased expression of myelinassociated genes in mice exposed to lithium car bonate. 41 In addition, we found that patients with BD who had documented moderate/high alcohol or illicit drug use had significantly greater oligodendrocyte densities than those with no/low alcohol or drug use. This appears con trary to previous reports of white matter loss and decreased expression of myelinrelated genes in chronic alcohol and co caine abusers. [42] [43] [44] However, increased expression of the oligodendrocyteassociated gene myelinassociated basic protein (MOBP) was noted in the DLPFC white matter in pa tients with schizophrenia who had a history of substance abuse. 17 In addition, we observed a 16% increase in MBP pro tein expression in patients with BD who had been prescribed antidepressants compared to those who had not been pre scribed antidepressants. This finding is consistent with that of Mosebach and colleagues, 13 who reported a trend toward increased MBP immunoreactivity with mean antidepressant dosage in patients with MDD. Further examination of the ef fects of psychotropic medications, alcohol and illicit drugs on white matter is warranted.
Few studies have examined astrocytes in white matter in the major psychiatric disorders. Williams and colleagues 15 reported decreased density of GFAPlabelled astrocytes in cingulate white matter in patients with schizophrenia, but not in those with BD, whereas Falkai and colleagues 45 found no significant change in astrocyte density in premotor white matter in individuals with schizophrenia. Astrocyte density did not differ among the groups in our study, although con trast analyses revealed a trend toward decreased astrocyte density in the schizophrenia group, and secondary analyses indicated that astrocyte density was significantly lower in psychiatric patients who died by means other than suicide than in controls. The GFAP area fraction was reduced in both psychiatric groups relative to controls, although this finding was no longer significant following inclusion of brain pH as a covariate in the model. The GFAP area frac tion was also lower in psychiatric patients who died by means other than suicide relative to controls. To our know ledge, GFAP area fraction has not previously been quanti fied in white matter in individuals with the major psychiat ric disorders, although decreased GFAP area fraction has been reported in prefrontal grey matter in individuals with schizophrenia. 46 Reduced GFAP area fraction could be the result of fewer, less complex or atrophied astrocyte pro cesses, decreased astrocyte density, downregulation of GFAP expression, or a combination of these factors. In addi tion, GFAPlabelled astrocytes exhibited significantly al tered spatial distribution in the schizophrenia and BD groups, such that astrocytes were more clustered in the psychi atric groups than the control group. Unlike the proto plasmic astrocytes present in grey matter, fibrous astrocytes in white matter are not organized into nonoverlapping spatial domains. However, their cell bodies are typically equally spaced, with their processes being radially oriented in the direction of the axon bundles; 47 this regular spacing arrangement is thought to reflect the structural support that fibrous astrocytes provide for axonal tracts. Increased astro cyte clustering could therefore result in disruption of struc tural support of axons in individuals with schizophrenia and BD.
There is a paucity of information on white matter micro glia in patients with schizophrenia and BD. We found no significant alteration in the density or distribution of IBA 1labelled microglia among the groups. Our data appear contrary to those of Fillman and colleagues, 18 who reported a 9% increase in microglial density in frontal white matter. However, it should be noted that our marker IBA1 labels both resting and activated microglial populations, whereas the human leukocyte antigen antibody used previously 18 is considered specific to activated microglia. Qualitative exam ination of our samples revealed areas of microglial ac tivation in 3 schizophrenia samples, but not in controls. We were not able to identify any obvious confounding reason for this finding (e.g., cause of death). Inflammation may therefore be present in a subset of patients with schizophre nia, consistent with findings in grey matter in individuals with this disorder. 48, 49 Limitations When interpreting our results some methodological limita tions should be kept in mind. First, we identified oligoden drocytes using a nonspecific histological stain, an approach used in several previous studies of this cell population. 9, [12] [13] [14] [15] This could lead to the misclassification of a small number of other cells as oligodendrocytes. However, we employed stringent morphological criteria and counted only round or oval cells with a diameter of 3-7 µm to exclude most OPCs, neurons, microglia and any unstained astrocytes. In addi tion, counting oligodendrocytes on GFAPstained sections reduced the possibility of misclassifying astrocytes as oligo dendrocytes. While GFAP is a poor marker of protoplasmic astrocytes in grey matter, it stains mature fibrous astrocytes in white matter much more robustly. 50 Other groups have quantified oligodendrocytes expressing CNPase, 9 olig1, 12 prohibitin 51 and ADAM12 52 in individuals with schizophre nia. CNPase immunohistochemistry was not consistent in our formalinfixed paraffinembedded tissue, a problem discussed previously. 15 Furthermore, prohibitin is not spe cific to oligodendrocytes, 51 while only a minority of white matter oligodendrocytes express ADAM12. 53 Second, tech nical limitations required 2dimensional measures of cell density and size to be acquired. The implications of 2 dimensional and 3dimensional counting methods have been discussed in detail previously. 54 One advantage of our method is that we were able to assess greater numbers of glial cells using larger sampling frames, thus allowing us to undertake spatial pattern analyses.
A further potential confounding influence is the use of medi cation in the psychiatric samples. While information was avail able regarding prescription of medications, we did not deter mine compliance. In addition to mood stabilizers and antidepressants, which have been discussed, several patients had been prescribed antipsychotics. The effects of these medications on white matter are poorly understood and may differ between typical and atypical classes. Animal and cell culture studies sug gest that antipsychotics may have protective and proliferative effects on immature and progenitor oligodendrocytes, [55] [56] [57] [58] al though decreased astrocyte number has been reported in mon keys exposed to antipsychotics. 59 We found no significant associ ation between antipsychotic dose and any measure.
Conclusion
To our knowledge, this is the first study to concurrently quantify oligodendrocyte, astrocyte and microglial densities in white matter in schizophrenia and BD samples. These data provide further evidence for a morphological basis for white matter abnormalities, which may contribute to dis rupted neural connectivity, in individuals with these disor ders. Our findings do not support a coordinated alteration in multiple glial cell populations and are not suggestive of a gliotic response. Increased oligodendrocyte density was specific to the BD group and could reflect a compensatory mechanism to restore damaged myelin. However, the influ ence of factors such as use of medications, alcohol and illicit drugs should be considered when interpreting our data. As trocyte spatial arrangement was compromised in individ uals with schizophrenia and BD. While astrocytes play mul tiple roles in white matter, we propose that these alterations may be associated with disturbances in myelin preservation or axonal support.
